SYS-CON MEDIA Authors: Mat Mathews, PR.com Newswire, David Smith, Tim Crawford, Kevin Benedict

News Feed Item

Cigarette Companies Report Stock Summaries, Dividends, Financial Results and Announcements - Analyst Notes on Lorillard, Reynold American, Altria Group, Philip Morris International, and Vector Group

Editor Note: For more information about this release, please scroll to bottom

NEW YORK, March 5, 2014 /PRNewswire/ --

Today, Analysts Review released its analysts' notes regarding Lorillard, Inc. (NYSE: LO), Reynolds American Inc. (NYSE: RAI), Altria Group Inc. (NYSE: MO), Philip Morris International, Inc. (NYSE: PM), and Vector Group Ltd. (NYSE: VGR). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.AnalystsReview.com/register

Lorillard, Inc. Analyst Notes

On March 3, 2014, Lorillard, Inc.'s (Lorillard) stock went up by 9.27% to $53.61 per share. The sudden surge in Lorillard's stock was preceded by the Financial Times reporting that RJ Reynolds, a US tobacco company, is exploring a bid for Lorillard. The Financial Times cited people familiar with the situation as the source for the news. The full analyst notes on Lorillard, Inc. are available to download free of charge at:

http://www.AnalystsReview.com/03052014/LO/report.pdf

--

Reynolds American Inc. Analyst Notes

On March 3, 2014, R.J. Reynolds Vapor Company (RJR Vapor Company), a subsidiary of Reynolds American Inc. (Reynolds American), announced that its VUSE® Digital Vapor Cigarette is the official vapor product (e-cigarette) of South by Southwest 2014 (SXSW) in Austin, Texas. Commenting on the release, Stephanie Cordisco, President of RJR Vapor Company, stated, "With a culture of innovation and focus on emerging trends, South by Southwest is the ideal setting to showcase the state-of-art, digital technology in VUSE that makes it a game-changer for the vapor industry. VUSE is redefining enjoyment for adult tobacco consumers, and plays a key role in our continued efforts to lead the transformation of the tobacco industry." The full analyst notes on Reynolds American Inc. are available to download free of charge at:

http://www.AnalystsReview.com/03052014/RAI/report.pdf

--

Altria Group Inc. Analyst Notes

On February 26, 2014, Altria Group Inc. (Altria) announced that the Company's Board of Directors has declared a regular quarterly dividend of $0.48 per common share. According to Altria, the regular quarterly dividend is payable on April 10, 2014, to shareholders of record as of March 14, 2014, and the ex-dividend date is March 12, 2014. The full analyst notes on Altria Group Inc. are available to download free of charge at:

http://www.AnalystsReview.com/03052014/MO/report.pdf

--

Philip Morris International, Inc. Analyst Notes

On February 26, 2014, Philip Morris International, Inc. (Philip Morris International) announced that the Company's EU Region President Drago Azinovic, has commented on the adoption by the European Parliament of the Tobacco Products Directive (TPD). According to the release, Azinovic stated, "The Tobacco Products Directive adopted by the European Parliament today represents a worrying departure from the EU's basic standards of proportionate, evidenced-based policymaking, which will further erode intellectual property rights and undermine the EU Charter where these rights are protected. Instead of further harmonizing the internal market, a stated objective of the Directive, measures in the TPD will make the EU less competitive and be a gift for the criminals profiting from the black market in tobacco. This will be a blow to the hundreds of thousands of people working in the legal industry and member state governments now faced with filling budget gaps." The full analyst notes on Philip Morris International, Inc. are available to download free of charge at:

http://www.AnalystsReview.com/03052014/PM/report.pdf

--

Vector Group Ltd. Analyst Notes

On March 3, 2014, Vector Group Ltd. (Vector Group) reported its Q4 2013 and full-year 2013 financial results. The Company's revenues for Q4 2013 were up by 6.3% YoY to $295.2 million, while full-year 2013 revenues went down by 2.6% YoY to $1.1 billion. Net income for Q4 2013 was $63.8 million or $0.61 per diluted share, compared to net income of $16.5 million or $0.14 per diluted share in Q4 2012. Full-year 2013 net income was $38.7 million or $0.41 per diluted share, compared to net income of $53.7 million or $0.34 per diluted share in 2012. The full analyst notes on Vector Group Ltd. are available to download free of charge at:

http://www.AnalystsReview.com/03052014/VGR/report.pdf

--

About Analysts Review
We provide our members with a simple and reliable way to leverage our economy of scale. Most investors do not have time to track all publicly traded companies, much less perform an in-depth review and analysis of the complexities contained in each situation. That's where Analysts Review comes in. We provide a single unified platform for investors' to hear about what matters. Situation alerts, moving events, and upcoming opportunities.

=============

EDITOR NOTES:

  • This is not company news. We are an independent source and our views do not reflect the companies mentioned.
  • Information in this release is fact checked and produced on a best efforts basis and reviewed by Nidhi Vatsal, a CFA charterholder. However, we are only human and are prone to make mistakes. If you notice any errors or omissions, please notify us below.
  • This information is submitted as a net-positive to companies mentioned, to increase awareness for mentioned companies to our subscriber base and the investing public.
  • If you wish to have your company covered in more detail by our team, or wish to learn more about our services, please contact us at pubco [at] AnalystsReview.com.
  • For any urgent concerns or inquiries, please contact us at compliance [at] AnalystsReview.com.
  • Are you a public company? Would you like to see similar coverage on your company? Send us a full investors' package to research [at] AnalystsReview.com for consideration.

COMPLIANCE PROCEDURE

Content is researched, written and reviewed on a best-effort basis. This document, article or report is prepared and authored by Analysts Review. An outsourced research services provider represented by Nidhi Vatsal, CFA, has only reviewed the information provided by Analysts Review in this article or report according to the Procedures outlined by Analysts Review. Analysts Review is not entitled to veto or interfere in the application of such procedures by the outsourced provider to the articles, documents or reports, as the case may be.

NOT FINANCIAL ADVICE

Analysts Review makes no warranty, expressed or implied, as to the accuracy or completeness or fitness for a purpose (investment or otherwise), of the information provided in this document. This information is not to be construed as personal financial advice. Readers are encouraged to consult their personal financial advisor before making any decisions to buy, sell or hold any securities mentioned herein.

NO WARRANTY OR LIABILITY ASSUMED

Analysts Review is not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted by Analysts Review whatsoever for any direct, indirect or consequential loss arising from the use of this document. Analysts Review expressly disclaims any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Analysts Review does not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.


SOURCE Analysts Review

More Stories By PR Newswire

Copyright © 2007 PR Newswire. All rights reserved. Republication or redistribution of PRNewswire content is expressly prohibited without the prior written consent of PRNewswire. PRNewswire shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.